Los Angeles-based Vitally Therapy AI has launched a wellness platform centered on live-action AI avatars, moving beyond static text chatbots to offer real-time video conversations. Designed by a physician, the tool aims to lower barriers to emotional support by providing an interactive, subscription-based alternative to traditional coaching.
Utilities often struggle to extract actionable intelligence from localized meter testing data, leaving critical revenue and performance insights trapped at the test bench. MARS Company is addressing this operational bottleneck with its new M3 Cloud platform, a reporting layer designed to make testing metrics accessible to enterprise decision-makers.
Chicago-based logistics marketing agency Position : Global secured two top industry accolades at the 2026 TMSA Elevate Conference in Denver, taking home the prestigious Trailblazer Award alongside a Rising Star honor for their work in integrating responsible artificial intelligence into modern supply chain communications.
.jpg?maxwidth=3030&maxheight=1950)
A decades-long mystery surrounding a private collection canvas has ended with the definitive attribution of Archimedes to Michelangelo Merisi da Caravaggio. Presented at a Monte Carlo symposium, the work stands as a collaborative effort from the artist’s final, turbulent years in Syracuse, verified by an exhaustive suite of modern forensic technologies.
Dental practices juggling fragmented relationships with multiple laboratories now have a unified digital dashboard for tracking cases and finances. Boston-based Incisive launched its new portal today, designed to eliminate the administrative friction of reconciling disparate billing systems, case statuses, and communication channels across various restorative vendors.
Dr. Shane Harrypersad of Vancouver-based Bold Therapeutics heads to Andover, New Hampshire, this week to spearhead discussions at the 2026 Metals in Medicine Gordon Research Conference, focusing on the complex transition of metal-based drugs from laboratory discovery to clinical application.
A single rejected offer of 16.9 ETH—valued at $74,705—has turned the 'Golden Elon' digital collectible into a lightning rod for debate. As the rarest piece in Cam Rackam’s Wall Street Bulls collection, the artwork has seen its value surge 300-fold, sparking claims that it represents a cultural milestone.
Consumer packaged goods companies now have a direct pathway to integrated revenue management as XTEL brings its flagship platform to the SAP Store. The move allows FMCG enterprises to link trade promotion planning and field sales execution directly with SAP S/4HANA and SAP Condition Contract Management environments.
San Diego-based LUXE Bidet is slashing the price of its W85 dual-nozzle attachment to $29.99, down from the standard $49.99, as part of the Walmart Deals event. The exclusive Pearl Gray model, designed for easy DIY installation, will be available exclusively through the retailer's online platform throughout the summer sales period.
In the Dorchester neighborhood of Boston, a new showroom is challenging the traditional retail model by replacing static product displays with an immersive culinary laboratory. The SKS Technicurean Center, a collaboration between luxury brand SKS and Yale Appliance, aims to demonstrate how high-performance technology integrates into modern residential kitchen design.
Dallas-based legal education leader BARBRI has acquired Lega, a platform specializing in hands-on artificial intelligence workshops and lab-based training. The move signals a shift in the legal sector from theoretical AI discussions toward building practical, real-world fluency for students, law firms, and seasoned practitioners across the globe.
A proposed $9.5 million cash settlement has been reached in a class action lawsuit against Eagle Pharmaceuticals, Inc., resolving claims brought by investors who purchased common stock between August 9, 2022, and October 1, 2024. The agreement now awaits final approval from the U.S. District Court in New Jersey.
For the fifth year running, Reston-based cybersecurity firm Electrosoft Services has been named a Top Workplace by WTOP News. The designation, which highlights the company's commitment to internal culture, relies exclusively on confidential feedback from staff regarding their professional support, growth opportunities, and overall workplace environment.
With more than six million annual deaths attributed to antimicrobial resistance, Lakewood-Amedex Biotherapeutics is bolstering its defenses. The Sarasota-based firm announced the issuance of an Australian composition of matter patent, further shielding its Bisphosphocin class of broad-spectrum antimicrobials currently under development for complex urinary and pulmonary infections.
After two decades leading commercial strategies for global pharmaceutical giants like Roche and Sanofi-Aventis, Raymond Rodriguez-Torres has been appointed president of First Ascent Biomedical. He joins the firm to scale its Functional Precision Oncology platform, bringing both corporate expertise and a long-standing personal commitment to pediatric cancer advocacy.
More than 3,000 residents flooded the streets of Evanston this Father’s Day, marking the 27th annual Ricky Byrdsong Memorial Race Against Hate. The event, a cornerstone of local activism, transformed a day of remembrance into a collective stand against the rising tide of racial injustice in the Chicagoland area.
Alvian Networks has formally launched its American subsidiary, Alvian USA Inc., anchoring its new operations at 1 Seneca Street in Buffalo, New York. This expansion aims to bolster the security of critical infrastructure across energy, telecommunications, and government sectors by providing advanced timing integrity and event validation technologies.
Orangetheory Fitness is stepping out of the studio and into the home gym, announcing a licensing agreement with Fit for Life to produce a line of branded training equipment. The partnership aims to extend the franchise's signature workout methodology to consumers through a new collection of fitness accessories arriving in early 2027.
DermDox Group has acquired Modern Aesthetics Plastic Surgery, a move designed to consolidate skin health and cosmetic services across the Mid-Atlantic. By integrating plastic surgery into its existing medical and surgical dermatology platform, the group aims to offer a unified continuum of care for both clinical and aesthetic patient needs.
Autonomous AI agents operate at machine speed, often bypassing traditional security protocols and creating risks that human oversight cannot catch. To bridge this gap, Palo Alto-based Anjuna Security has unveiled Anjuna Overwatch, a governance layer designed to secure agentic systems using hardware-enforced confidential computing.
St. Paul-based manufacturing giant 3M has launched Ask 3M, an AI-driven digital assistant designed to provide industrial customers with instant, self-service access to technical expertise. Accessible via a dedicated portal, the tool aims to reduce product discovery timelines by grounding its responses in verified corporate documentation and engineering data.
By merging Validic’s extensive personal health data infrastructure with its own specialized clinical services, Greenville-based ChartSpan is shifting the remote care model from periodic check-ins to continuous monitoring. This acquisition aims to bridge the data gap between provider visits, allowing care teams to intervene before acute health episodes occur.
By launching its flagship Soprano Titanium device in Thailand, Sisram Medical is accelerating a dual-growth strategy that pairs energy-based technology with high-demand injectables. The company aims to leverage Thailand’s robust medical tourism sector as a springboard to capture broader market share across the competitive Southeast Asian aesthetic landscape.
After a five-year, parent-led mission to bridge the gap in rare disease research, six-year-old Riaan Singh Digeorge has become the first person treated with experimental gene therapy for Cockayne syndrome. The procedure took place this April at NewYork-Presbyterian Komansky Children’s Hospital, marking a historic shift in pediatric drug development.
As artificial intelligence reshapes the labor market, Autodesk is launching a $350 million initiative to prepare the next generation for careers in design and manufacturing. The three-year commitment aims to provide essential tools, training, and professional certifications to students and workers navigating an increasingly automated industrial landscape.
Luxury hospitality is shifting from transaction-based service to persistent, membership-driven relationships. Naples-based Uptown Network has introduced Artuzan, a unified platform designed to implement Guest Experience Architecture, a framework intended to bridge the gap between fragmented digital tools and long-term guest retention across hotels and fine dining.
Conflict serves as the catalyst for the modern battlefield, where low-cost, coordinated drone swarms now overwhelm traditional defenses. Rocket One is responding to this shift with Swarm Stage AI, an autonomous simulation platform designed to help military and security forces train against saturation attacks and adaptive electronic warfare.
As lithium-ion battery fires become a frequent hazard for emergency teams, Toronto-based Full Circle Lithium is bringing its FCL-X suppression technology to the National Fire Protection Association Conference in Las Vegas. The company aims to position its specialized extinguishers as the new standard for volatile battery-related incidents.
With 1,053 lives lost to alcohol-related crashes in Texas in 2024, Houston-based Armstrong Lee & Baker LLP is attempting to curb holiday tragedy by launching a reimbursement program for rideshare services. The initiative covers cab, Uber, or Lyft fares for Houston residents to ensure they arrive home safely this Independence Day.
With backing from Skeleton Key and Merck Global Health Innovation Fund, Montreal-based DropGenie has closed a Seed+ financing round to move its gene editing platform toward full commercial launch. The startup aims to transform drug discovery by miniaturizing workflows to allow direct experimentation on primary patient cells.
